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Summary 
 
The search for developmental mechanisms driving vertebrate organogenesis has paved the way 
toward a deeper understanding of birth defects. During embryogenesis, parts of the heart and 
craniofacial muscles arise from pharyngeal mesoderm (PM) progenitors. Here, we reveal a 
hierarchical regulatory network of a set of transcription factors expressed in the PM that initiates 
heart and craniofacial organogenesis. Genetic perturbation of this network in mice resulted in heart 
and craniofacial muscle defects, revealing robust cross-regulation between its members. We 
identified Lhx2 as a novel player during cardiac and pharyngeal muscle development. Lhx2 and 
Tcf21 genetically interact with Tbx1, the major determinant in the etiology of DiGeorge/velo-cardio-
facial/22q11.2 deletion syndrome.  Furthermore, knockout of these genes in the mouse 
recapitulates specific cardiac features of this syndrome. We suggest that PM-derived 
cardiogenesis and myogenesis are network properties rather than properties specific to individual 
PM members. These findings shed new light on the developmental underpinnings of congenital 
defects. 
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Introduction 
Embryonic development encompasses an orchestrated series of cellular events; even subtle 
alterations in this process can lead to serious disorders. Gene regulatory networks are thought to 
play key roles during organogenesis. Such developmental networks have been identified in 
Echinoidea (sea urchin), Drosophila, Ciona intestinalis and C.  elegans (1); the characterization of 
gene regulatory networks during vertebrate organogenesis lags behind.  
 
Pharyngeal mesoderm (PM) cells are a subset of the head mesoderm, contributing to broad 
regions of the heart and head musculature. The PM contains initially both paraxial and splanchnic 
mesoderm cells surrounding the pharynx. Later, these cells migrate to fill the core of the 
pharyngeal arches, also known as branchial arches (2). Prior to their differentiation, PM cells 
express both skeletal muscle and second heart field markers. Thus, the genetic program 
controlling early pharyngeal muscle development overlaps with that of the heart; the major 
molecular players include the transcription factors Tbx1, Pitx2, Tcf21 (capsulin/Pod1), Islet1 and 
Msc (MyoR) (2-5).  
 
In addition to pharyngeal muscles, PM cells also contribute to the arterial pole of the heart, 
following the formation of the linear heart tube. Perturbations in the recruitment of PM-derived cells 
to the heart tube can lead to a wide range of congenital heart defects. Such defects occur in nearly 
1% of live births, reflecting the complex cellular processes underlying heart development (6-8). 
Cardiac and craniofacial birth defects are often linked, due to their anatomical proximity during 
early embryogenesis and overlapping progenitor populations (2-4). One such congenital defect is 
DiGeorge syndrome (DGS), the most frequent microdeletion syndrome in humans, with an 
estimated incidence of 1 in 4,000 live births (9, 10). Its clinical features vary, and may include 
cardiac defects, craniofacial and aortic arch anomalies, as well as thymus and parathyroid gland 
hypoplasia.  
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The T-box transcription factor 1 (TBX1) is located in the 22q11.2 deleted region, and mutations in 
TBX1 have been found in some patients with DGS-like phenotype; therefore, TBX1 
haploinsufficiency is probably a major contributor to human del22q11 phenotypes, and to murine 
models of the syndrome (11-14).  
 
How does a set of PM transcription factors execute myogenesis and cardiogenesis? What are the 
relationships between these factors? Could we identify new PM regulators? In this study we have 
addressed these questions in mice by revealing a hierarchical regulatory network, composed of a 
set of transcription factors expressed in PM progenitors. A comprehensive genetic study 
uncovered novel molecular evidence for the involvement of the PM regulatory network in 
myogenesis and cardiogenesis as well as in the etiology of DGS. 
 
 
Results  
In order to identify novel regulators of PM myogenic progenitors, we compared gene expression 
patterns of PM-derived progenitors, to those derived from the trunk (somites) at early stages of 
embryonic development in the mouse (E9.5-E11.5). Myf5 is the earliest marker of myogenic 
commitment (15). In Myf5Cre;Rosa26YFP
 
double heterozygous embryos the entire skeletal muscle 
lineage is YFP+ (Fig. 1A'). We FACS-purified PM and trunk myogenic progenitors separately, and 
evaluated their gene expression profiles using an Affimetrix array (Fig. 1A-D). Our results 
confirmed the differential expression of previously described PM-specific transcription factors such 
as Tcf21, Isl1, Tbx1, Msc, Pitx2, and Nkx2.5 (Figs. 1E and S1). Other markers, such as Tlx1 (16), 
Six2 (17), the endothelial marker Lmo2 (18), the endothelin signaling component Edn1 (19), and 
retinoic acid-related genes were identified in our screen, and were enriched in PM, compared to 
the trunk progenitors (Figs. 1E and S1). As expected, Pax3, the key myogenic regulator of trunk 
skeletal muscles, was not expressed in PM progenitors. Consistent with the fact that myogenic 
differentiation in head muscle progenitors lags behind that of the trunk, we observed delayed 
activation of muscle contractile genes such as myosins (e.g. Myh3) and troponins (e.g. Tnni1) in 
the PM, relative to trunk muscle progenitors (Fig. 1E).  In addition, we identified Lhx2, a LIM 
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domain-containing transcription factor, as a novel PM-specific gene. In situ hybridization revealed 
that Lhx2 is expressed in the mesodermal core of the pharyngeal arches (Fig. 1F-I), while 
completely absent from the somites. In mice, Lhx2 is a prerequisite for the development of several 
organs, including the eye, telencephalon, and blood system (20-22), which fits its expression in 
these tissues (Fig. 1F-I).  
 
In order to obtain detailed expression relationships of Lhx2 relative to other lineages within the 
pharyngeal arches we immunostained control E9.5 embryos with antibodies to Lhx2, Isl1, AP2 and 
Pecam1 (Figs. 1J-L and S2). Most cells in the core of the arch express both Lhx2 and Isl1. In 
contrast, Lhx2 is not expressed in neural crest (AP2) or endothelial (Pecam1) cells (Figs. 1J-L and 
S2). Isl1 is expressed in, and required for a broad subset of cardiac progenitors in the mouse (23, 
24). Isl1 is expressed in the distal part of the PM and these cells contribute to both pharyngeal 
muscles (and their satellite cells) as well as to the heart (2). A stream of Lhx2+ Isl1+ PM cells can 
be seen connecting the second pharyngeal arch and the outflow tract (OFT). Taken together, the 
expression pattern of Lhx2 in Isl1+ PM progenitors suggests that this gene might play a role in both 
myogenesis and cardiogenesis processes. 
 
Next we determined the genetic interactions between the major PM factors at E9.5 (Fig. 2). To 
systematically examine the epistatic relationships between the major PM regulators, we used 
several mouse knockout models (Figs. 2 and S3). While Tbx1 and Tcf21 expression patterns 
remained unchanged in Lhx2 mutant embryos (Fig. 2A-B'), Lhx2 expression was reduced in the 
PM of Tbx1 mutant embryos at the same developmental stage (Fig. 2C,C’). These results suggest 
that Lhx2 acts downstream of Tbx1. The expression levels of Tcf21, Msc and Pitx2, were slightly 
increased in the PM of Tbx1 mutant embryos, consistent with findings from a recent screen for 
Tbx1 target genes (25) (Figs. 2D,D' and S3), suggesting that these factors are regulated by Tbx1.  
 
Next we examined how the bHLH factor Tcf21 affects the PM regulators. It was previously shown 
that a subgroup of pharyngeal muscles was absent in Tcf21/Msc double knockout embryos (26). 
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Furthermore, these two genes have been shown to regulate the expression of MyoD and Myf5 in 
craniofacial muscle progenitors (27). The expression of Lhx2, Tbx1 and Pitx2 was reduced in the 
PM of Tcf21 mutant embryos (Figs. 2E-F' and S3). These findings place Tcf21 in the upper tier of 
the PM genetic network.  
 
Finally we have characterized the bicoid-related homeodomain transcription factor Pitx2. Both 
pharyngeal muscles (derived from the first arch) and extraocular muscles (EOM) were affected in 
Pitx2 knockout embryos (17, 28). Pitx2 and Tbx1 were shown to be genetically linked in many 
developmental processes, including cardiac and craniofacial muscle development (3). In Pitx2 
knockout embryos, Tbx1 was hardly detected in the PM, and Lhx2 was diminished specifically in 
the mesoderm of the first pharyngeal arch (Fig. S3). We confirmed the observed changes in gene 
expression using qRT-PCR on isolated pharyngeal arches (1st-3rd) of various mutant embryos (Fig. 
S4). The results are consistent with the gene expression patterns observed by in situ hybridization 
(Figs. 2 and S3). Notably, some of the analyzed genes (e.g., Pitx2 and Tbx1) are also expressed in 
the ectoderm and endoderm of the pharyngeal arches; accordingly their total levels were 
moderately changed compared to the in situ hybridization results (Fig. S4). Notably, despite some 
loss of PM cells in Pitx2 mutants at E9.5, which underscores the importance of Pitx2 in PM cell 
survival (17, 28), the observed changes in gene expression patterns could not be attributed to loss 
of PM cells (Fig. S4B). Our findings reveal cross-regulation between members of the PM network: 
Tcf21 and Pitx2 are linked to Tbx1, while Lhx2 lies downstream to these genes.  
 
A key question regarding our findings is whether the observed changes in PM gene expression 
(Figs. 2A-F’ and S3) are due to direct interactions between the PM transcription factors. Chromatin 
immunoprecipitation (ChIP) was performed on isolated E9.5 pharyngeal arch tissues using Tbx1, 
Pitx2 and Tcf21 antibodies in order to evaluate a potential cross regulation between PM members. 
Our results suggest several interactions, the strongest of which are Tbx1, Pitx2 and Tcf21 with 
Pitx2 proximal promoter (Fig. 2G). Due to the extensive interactions of Pitx2 with other PM 
members, we decided to further characterize its specific binding sites using ChIP-seq. Pitx2 
binding to Tbx1, Tcf21 and Lhx2 regulatory regions was enriched in isolated E9.5 pharyngeal arch 
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tissues (Fig. 2H). As a control, we compared the binding of Pitx2 to these elements in Pitx2-/- 
derived tissues, binding of Pitx2 to non-specific genomic sites, as well as binding of non-specific 
antibody (Figs. 2H and S5). Although Pitx2 did not bind to the Tbx1 proximal promoter, we could 
identify its binding to specific sites upstream to the promoter using a ChIP-seq approach (Figs. 2H 
and S5). Taken together, our findings suggest that the PM regulatory network involves extensive 
genetic interactions between its members (Fig. 2I). 
 
The involvement of Lhx2 in cardiac and craniofacial development was not previously examined, 
partly due to the fact that Lhx2 knockout mouse embryos die at E15.5 (20). Therefore, we first 
sought to address its role during head muscle development (Fig. 3). Pax7 marks muscle 
progenitors whereas MyoD defines a more committed myogenic state. At E11.5, the total number 
of myogenic cells (Pax7+ or MyoD+) in the PM of Lhx2 mutant embryos decreased by 
approximately 50% (Fig. 3A-F). Comparing the ratio between MyoD and Pax7 expressing cells in 
control vs. Lhx2 mutants revealed that the Pax7+ population was more affected, suggesting that 
Lhx2 is required in PM-derived muscle progenitors.  
 
A decrease in the number of muscle progenitors could be due to either a delay in the specification 
of PM cells toward the myogenic lineage, a decrease in their proliferation, or elevated apoptosis. 
To resolve this issue, we compared myogenic (Pax7+-MyoD+) vs. pre-myogenic PM progenitors 
expressing Isl1+. Isl1 expression is downregulated rapidly as head myogenesis ensues, and Isl1 
overexpression in chick embryos delayed myogenic differentiation (29, 30). In Lhx2 mutants, Isl1 
expression failed to be downregulated in the core of the 1st pharyngeal arch compared to controls 
(Fig. 3G-I), while cell proliferation and apoptosis remained comparable (Figs. 3J-L and S6). The 
observed increase in pre-myogenic Isl1+ cells in Lhx2 mutants was inversely correlated with the 
number of Pax7 expressing cells, suggesting that Lhx2 is involved in pharyngeal muscle 
specification. 
 
Myf5 is highly regulated, both spatially and temporally by various factors (31). In order to further 
examine the role of Lhx2 during head muscle specification, we utilized the Myf5nLacZ reporter (32). 
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Myf5 expression in the pharyngeal arches was reduced in Lhx2 mutant compared to control E11.5 
embryos, while trunk and extraocular muscles (EOM) remained unaffected (Fig. 3M,N; n12). 
These findings demonstrate that Lhx2 is required for the early activation of Myf5 in the myogenic 
specification program within the pharyngeal arches. The expression of Myf5 (LacZ staining) was 
largely restored at E14.5, albeit with some patterning defects (Fig. 3O,P). Hence, the PM 
regulatory network acts to provide robustness by allowing the activation of the myogenic program 
in the absence of a single PM member, consistent with previous studies (16, 33). 
 
Next, we examined whether Myf5 is directly regulated by the members of the PM network by in-
vivo ChIP. Tbx1, Pitx2 and Tcf21 were associated to the Myf5 evolutionary conserved region 
(ECR-84), which is part of the mandibular arch enhancer (MAE, Fig. S5) (31). To further explore 
the connection between Lhx2 and Myf5, we identified three putative Lhx2 binding sites within the 
Myf5 MAE. Next, C2C12 cells, transfected with Lhx2-HA construct were used for a ChIP 
experiment using anti-HA antibody. We found that Lhx2 can bind to one of these sites in C2C12  
cells (Fig. S5).  
 
To further validate the robust nature of the myogenic program in the head we compared single 
knockouts of PM factors (Fig. 4A-D). Knockout of Lhx2, Tbx1 and Tcf21 separately, revealed 
muscle patterning defects in all three mutants (Fig. 4A-D). In agreement with an earlier report (16), 
pharyngeal muscles are severely perturbed, though not completely eliminated, in Tbx1í/í mutants 
[(Fig. 4C and (16, 33)]. In order to investigate the genetic wiring of the PM regulators, we analyzed 
the muscle phenotype in double knockout embryos (Fig. 4E-I). The muscle phenotype in Tbx1í/í 
mutants was comparable to that of Tbx1í/í;Lhx2í/+ mutants (Fig. 4C,E). Remarkably, pharyngeal 
arch muscles were completely missing in Tbx1í/í;Lhx2í/í double mutants (Fig. 4F; n=2/4). 
Likewise, pharyngeal muscles were eliminated in most Tbx1í/í;Myf5í/í mutants (Fig. 4G; n=3/4), in 
agreement with (33).  
 
Taken together, our findings reveal that Tbx1, Lhx2, Myf5 genetic circuit is required for pharyngeal 
muscle specification. Our findings suggest that in the absence of both Myf5 and Lhx2, Tbx1, could 
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initiate myogenesis by activating MyoD via a parallel genetic pathway, as suggested by (33). 
Accordingly, pharyngeal muscles of Tbx1í/í;MyoDí/í double mutants were completely missing (with 
the exception of the digastric muscles in the lower jaw) (Fig. 4I; n=2/2). Hence, in the absence of 
Tbx1 and another factor (e.g., Lhx2, Myf5, or MyoD) pharyngeal muscles are severely perturbed. 
Consistent with the key role of Tbx1 in this genetic network, Myf5í/í;Lhx2í/í and MyoDí/í;Lhx2í/í 
double-knockout embryos did not show an enhanced muscle phenotype, compared to each 
knockout alone (Figs. 4H and S4). Our findings suggest that the PM network acts to ensure proper 
myogenesis in the absence of single PM members (Fig. 4J). 
 
DGS is a common congenital disease involving cardiac and craniofacial defects. The major genetic 
determinant in its etiology is TBX1, although other genes in the 22q11 region have been shown to 
be involved. Because Lhx2 lies downstream of Tbx1 We hypothesized that Lhx2 mutant embryos 
might display DGS phenotypes. Lhx2 mutants die at E14.5-15.5 from severe anemia and 
developmental defects (20). The development of the ventricular septum, is completed at E15, thus 
we analyzed both standard and conditional Lhx2 null embryos around this stage. Lhx2 was ablated 
in the cardio-craniofacial mesoderm using the MesP1Cre mouse line (34), which prolongs their 
viability up to birth. Indeed, at E17.5, about 50% of MesP1Cre+/-;Lhx2-/floxed (Lhx2mKO) mutants 
exhibited DGS-like cardiac defects, including various outflow-tract anomalies such as ventricular 
septal defect (VSD),  tetralogy of Fallot (TOF),  and double outlet right ventricle (DORV) (Fig. 5; 
n=7/13; and Supplementary Table 1). Interestingly, aortic arch patterning, one of the most common 
features of DGS, was normal in all Lhx2mKO mutants (n=13/13; and in E14.5 Lhx2-/- embryos 
n=10/10; Fig. 5A-E and Supplementary Table 1).  
 
We next investigated the genetic interaction between Tbx1 and Lhx2, by measuring the frequency 
of VSD in compound mutants. While Tbx1+/- heterozygous embryos had no detectable VSD (n=11), 
20% of Tbx1+/-Lhx2+/- double heterozygous (compound) embryos had VSD (n=10) (Supplementary 
Table 1). This functional interaction strongly suggests that Tbx1 and Lhx2 are in the same genetic 
pathway and synergistically regulate heart morphogenesis. 
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In order to identify genes lying downstream of Lhx2, we examined the expression of several 
possible candidates. The expression levels of both Fgf8, which is genetically linked to Tbx1 in the 
context of DGS (35), and Bmp4, which was shown to act downstream of Lhx2 during eye 
development (36), were comparable in Lhx2 mutant and control embryos (Fig. S7A-D). Several 
recent studies have shown that both cardiac neural crest (affecting caudal PM progenitors) and 
cranial neural crest cells (affecting rostral/cranial PM progenitors) influence the migration of PM 
cells into the looping heart, and their subsequent differentiation (2, 37). We therefore examined the 
expression pattern of several neural crest markers, Dlx5, Twist and Sox10 as well as the PM 
marker, Isl1. Although Isl1, Dlx5 and Twist expression seemed to be comparable in Lhx2 mutants 
and controls, Sox10 expression pattern was slightly perturbed in some mutants, suggesting that 
neural crest cell migration might play some role in the observed phenotype (Fig. S7E-J). These 
findings suggest that perturbation of the PM regulatory network affects cardiac formation both cell 
autonomously and non-cell autonomously, via crosstalk with neural crest cells.   
  
Given the regulatory interactions between various network members, we hypothesized that 
elimination of each of the core factors, one-by-one, might elicit a DGS-like phenotype either 
directly, or by affecting Tbx1 levels. Consistent with this view, Pitx2 is known to affect cardiac 
development (38, 39). Because Tbx1 levels were reduced in Tcf21 mutants (Fig. 2) we sought to 
better analyze the heart phenotype of these mutants. Tcf21 mutants display TOF, including VSD, 
overriding aorta, pulmonic stenosis (Figs. 5N-R, S8 and Supplementary Table 1) as well as cleft 
palates (Fig. 4D). Similar to Lhx2mKO mutant embryos, the morphology of the aortic arch remained 
normal in Tcf21 mutants. Furthermore, hearts of Tcf21-/- mutants displayed regions of epicardial 
detachments (Fig. S8) in agreement with a recent report (40). Taken together, insights from the PM 
network composition, led us to predict that both Tcf21 and Lhx2, which are genetically linked to 
Tbx1, might cause cardiac defects. We demonstrate such cardiac anomalies in both Tcf21 and 
Lhx2 mutant embryos, some of which are shared by DGS patients. 
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Discussion 
Our results demonstrate that a set of transcription factors expressed in PM progenitors form a 
regulatory network that coordinates normal heart and craniofacial development (Fig. 6A). The 
expression of PM members (Tbx1, Pitx2, Tcf21, and Lhx2) is regulated by other members of the 
network, and involves direct genetic interactions. Lhx2 is a novel player within the PM network; 
knockout of this gene resulted in a pharyngeal muscle specification defect, as well as DGS-like 
phenotypes (Fig. 6A). We revealed epistatic relationships between Tbx1, Lhx2, and Myf5 
embedded within the PM network, affecting early pharyngeal muscle specification and patterning. 
Thus, Lhx2 plays an important role in PM progenitor cells, consistent with its roles in the 
specification of other stem/progenitor cell populations such as telencephalic progenitors (41); retina 
progenitors (42); hematopoietic progenitors (43); and hair follicle progenitors (21).   
 
In addition, we revealed a genetic link between Tcf21, Tbx1, and Lhx2 in the PM transcriptional 
circuit. Genetic perturbation of these factors resulted in specific DGS-like phenotypes. We 
demonstrated using single and double knockout experiments that Lhx2 removal has specific 
cardiac phenotypes, and it enhances the severity of both craniofacial muscles and heart 
phenotypes of Tbx1 mutants. This suggests that both genes work in the same genetic pathway. 
Hence, Lhx2 can be included within the growing list of transcription factors that have been found to 
play important roles in second heart field development, based on the cardiac phenotypes of single 
and compound mutations in these genes (44).  
 
Although human TCF21 and LHX2 do not map to chromosome 22q11.2, the shared morphological 
defects and link to Tbx1 suggest that these genes might be genetic modifiers of DGS. Genetic 
variations in the ISL1 locus in human were shown to be linked to an increased risk for congenital 
heart defects (45). Could LHX2 and TCF21 contribute to the variations in cardiovascular phenotype 
seen in DGS patients? To draw genotype-phenotype correlations in such patients, a genome-wide 
association study, as well as a candidate gene approach, is currently underway. Results from this 
study could shed light on whether common DNA variants alter the degree of expressivity of the 
syndrome. 
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One of the enigmatic features of DGS is that it varies in its penetrance from patient to patient. 
Importantly, some DGS patients do not display neither a deletion nor a mutation in the Tbx1 locus 
(46). Changes in the levels of Tbx1, loss and gain, lead to a dose-dependent spectrum of DGS 
malformations (47, 48). Therefore, Tbx1 levels must be precisely regulated, in order for the 
pharyngeal apparatus and its derivatives to properly form. Our study adds to the understanding of 
how Tbx1 levels could be fine-tuned by interactions with other PM transcription factors (Fig. 6A).  
 
Tbx1 is expressed in both rostral and caudal PM cells. It has been shown that cranial PM cells 
enter the arterial pole of the heart to populate the RV and OFT, while caudal PM cells contribute to 
the myocardium at the base of the great arteries (49). Previous studies addressing DGS etiology 
reported various cardiac anomalies, including both aortic arch and cardiac defects, for the following 
knockout models: Fgf8 and Six1/Eya1 (35), VegfA (50) and retinoic acid-related genes (51). We 
suggest that Lhx2 and Tcf21, expressed in the cranial PM, function as domain-specific modifiers of 
the Tbx1 pathway, as judged by the uncoupling of the aortic arch phenotype from that of the 
outflow tract (Fig. 6B). In sum, our study sheds light on the developmental principles underlying the 
etiology of congenital birth defects. 
 
Our findings imply that the heart and pharyngeal muscles show varying degrees of sensitivity to 
early perturbations of the PM. For example, while the pharyngeal muscle phenotypes of Lhx2 and 
Tcf21 mutants are largely restored, albeit with patterning/hypoplastic defects, the cardiac defects 
are beyond repair. Detailed analyses of pharyngeal muscles in mouse and zebrafish DGS models 
(or in human patients) have not been well-characterized. Facial asymmetry, for example, is a rare 
symptom observed in babies only when they cry, known as “asymmetric crying faces,” is caused 
by the absence or hypoplasia of a pharyngeal muscle at the corner of the mouth. This defect has 
been shown to be associated with cardiovascular anomalies in DGS babies (52). Therefore, it 
would be important to better characterize the linkage between craniofacial muscle patterning and 
cardiovascular defects.  
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Regulatory networks of transcription factors have been found in diverse organisms, from bacteria 
to humans. The network architectures of the transcription factors function to enhance the stability 
of gene expression and functional outputs. The PM network characteristics that we (this study) and 
others (16, 17, 28, 33) have gradually uncovered in recent years seem to be hierarchical, and 
involve extensive cis-regulatory interactions. We propose that the overall biological outputs of the 
PM network (e.g., cardiogenesis and myogenesis) and precise signal strengths are network 
properties, rather than properties specific to individual PM members.  
Experimental Procedures 
Mice 
The following mouse transgenic lines and their genotyping have been previously described: 
Myf5Cre (53), Rosa26YFP (54), Pitx2-/- (55), Myf5nlacZ (32), MesP1Cre (34), Lhx2sKO (20), Lhx2cKO (22), 
Tcf21-/- (56) and Tbx1-/- (11).  
 
FACS, Microarrays, Staining, qPCR and ChIP  
Inter-limb somites and pharyngeal arches were dissected from E9.5, E10.5 and E11.5 
Myf5Cre;RosaYFP mouse embryos. RNA was purified amplified, and hybridized to Affymetrix arrays 
(detailed in the Supplementary Information). X-Gal staining, histology, immunohistochemistry and 
whole-mount in situ hybridization were performed as previously reported (29). Antibodies are listed 
in the Supplementary Information. cDNA or immunoprecipitated (IP) DNA was analyzed by qPCR 
using SYBR Green methodology as recommended by the manufacturer. Primers used are listed in 
supplemental Table 2. The ChIP was done according to (57). Minor modifications and antibodies 
used are detailed in the Supplementary Information.  
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 Figure 1: Lhx2, a novel pharyngeal mesoderm regulator 
A-D, Experimental design: a Myf5Cre;Rosa26YFP E11.5 embryo is shown under bright light and a 
fluorescence microscope (A,A’). Dotted lines indicate the dissected regions of the pharyngeal 
arches (B,B') and inter-limb somites (C,C'). YFP+ cells from these two tissues were isolated by 
FACS (indicated as R1 in D), and used for RNA transcriptome analysis (E). A comparison of gene 
expression profiles from head (PM, blue) and trunk (somites, magenta) muscle progenitors. The 
fold change corresponds to the difference in signal intensities (E). In situ hybridization for Lhx2 at 
E8.75 (F), E9.5 (G), E10 (H) and E11 (I) embryonic stages matches the microarray data. J-L, 
Transverse sections of control E9.5 embryos, representing the area depicted in (G), co-stained 
with Lhx2 and either AP2 (J) or Isl1 (K-L).  Dotted lines in (L) indicate the continuum of PM 
between the pharyngeal arches and the heart. Black arrowheads indicate Lhx2 expression in the 
PM (F-I), whereas white arrowheads indicate lack of expression in the inter-limb somites (G). 
1st/2nd/3rd – first/second/third pharyngeal arches; OFT – out flow tract. Scale bars: 300 ȝm. Error 
bars indicate standard error. 
 
Figure 2: Genetic interactions between members of the PM network 
A-F', Whole-mount in situ hybridization for the indicated genes (left) in E9.5 embryos with the 
indicated genotypes (black rectangles). Arrows/Arrowheads mark the PM: white arrows, 
unchanged expression; black arrowheads, down-regulated genes; white arrowheads, upregulated 
genes. G, A ChIP experiment using pharyngeal arch tissues at E9.5 with Tbx1, Pitx2 and Tcf21 
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antibodies. H, A ChIP-seq experiment using Pitx2 antibody on Pitx2+/+ and Pitx-/- pharyngeal 
arches, reveals specific interactions with Tcf21, Tbx1 and Lhx2 regulatory regions. I, A model 
summarizing direct (blue) and indirect (grey) genetic interactions in the PM regulatory network. 
TSS - transcription start site (or proximal promoter); MAE - mandibular arch enhancer. Asterisks 
point to the indicated TF binding site. Number of embryos in each experiment was 3. 
 
Figure 3: Lhx2 is required for specification of pharyngeal muscle progenitors 
A-C, Transverse sections of control (A) and Lhx2 mutant (B) E11.5 embryos, showing the core of 
the 1st pharyngeal arch, as indicated in C. Dotted lines in A and B represent the magnified areas in 
D-K. D-F, Co-immunofluorescence of Pax7 and MyoD in controls (D) and Lhx2 mutants (E), and 
quantification of the results (F). G-I, Co-immunofluorescence of myogenic (Pax7 and MyoD) vs. 
pre-myogenic (Isl1) in controls (G) and Lhx2 mutants (H) and quantification of the results (I). J-L, 
Co-immunofluorescence of myogenic (Pax7-MyoD) and phosphorylated histone H3 (P-H3), which 
labels mitotic cells in controls (J) and Lhx2 mutants (K). The percentage of proliferating myoblasts 
is quantified (L). Quantifications were performed on 6 sections from at least two different 
embryos, as shown in A–L. Error bars indicate standard deviation. Antibodies used and DAPI are 
written in individual panels, in the color corresponding to the fluorescent staining. M-N, Myf5 
expression (X-Gal staining) in Lhx2 control (M) and mutants (N) E11.5 embryos, which are also 
heterozygous for the Myf5nLacZ reporter. Insets in M-N show the area depicted by the dotted line in 
M. O-P, Myf5 expression (X-Gal) in Lhx2 control (O) and mutant (P) E14.5 embryos, which are also 
heterozygous for the Myf5nLacZ reporter. Arrowheads indicate change in muscle patterning. eom- 
extraocular muscles, 1st/2nd – first/second pharyngeal arch muscle progenitors, fl – forelimb, som – 
somites. 
 
Figure 4: Epistatic genetic relationships regulating pharyngeal muscle development 
A-J, Transverse craniofacial sections of E14.5 mouse embryos stained with MyHC for single (B-D) 
and double (E-J) mutants for the indicated genotypes (n 4). Dotted line outlines the cleft palate 
seen in all three single mutants (B-D). J, A model summarizing the genetic interactions described 
above. Dotted arrows indicate parallel regulatory interactions affecting head myogenesis, empty 
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arrowheads indicate novel interactions. Skeletal muscle groups are marked in white arrowheads, 
and their absence in black arrowheads. eom- extraocular muscles, 1st/2nd – first/second pharyngeal 
arch-derived muscles, tng - tongue. 
 
Figure 5: Lhx2 and Tcf21 mutant embryos display specific DGS-like cardiac defects 
A-E, Whole-mount E17.5 controls (A-B) and Lhx2mKO mutants (D-E), both displaying normally 
shaped aortic arches (B, D respectively). Note severe anemia in the mutant (D) embryo, as 
compared to control (A). A scheme illustrating the normal configuration of the aortic arch (C). F-G, 
Hematoxylin and Eosin (H&E) staining of heart paraffin sections in control hearts. F-M, Lhx2mKO 
mutants display a simple ventricular septal defect (VSD) (H-I, arrow), schematically illustrated (H); 
tetralogy of Fallot (TOF), characterized by both VSD and overriding aorta (J-K, arrows); Double 
outlet right ventricle (DORV, L-M). N-S, E17.5 Tcf21 mutant embryos display TOF, VSD, and 
overriding aorta (O) as compared to a control heart (N). In addition E17.5 Tcf21 mutant embryos 
have pulmonic stenosis, shown by vascular casting (Q) and H&E staining (S) compared to controls 
(P and R respectively). rs – Right subclavian artery; ls – Left subclavian artery; rc – Right common 
carotid artery; lc – Left common carotid artery; aa – Aortic arch; a – Aorta; p – Pulmonary artery; lv- 
Left ventricle; la- Left atrium; rv- Right ventricle; ra- Right atrium. The left side of the mouse is 
displayed on the right side of the picture, in all panels. 
 
Figure 6: PM progenitors form a regulatory network that coordinates early cardiogenesis 
and craniofacial myogenesis 
A. A summary of the genetic interactions of the PM transcriptional network and its impact on 
cardiogenesis and myogenesis. B. A proposed model for a domain specific subdivision of DGS-like 
anomalies in mouse models into rostral (heart and craniofacial) and caudal (arch artery) 
phenotypes. The model is based on the progressive alignment of the pharyngeal arches with the 
heart tube during its looping stages (50). The corresponding mouse knockout phenotypes are 
shown along these two domains.  
 
Primers for Fig. 5A 
ChIP-qPCR 
Msc_prom  F GGCCTAAGTCTTTGCTTTGC R  TCCGGATCCAAAAGTACAGC 
Tcf21_prom_F1 F 
 
AAAGGGGCCTTAGGAGATGA R CGAGGAATTTGGTGGACACT 
Pitx2ab_prom  F TCCTTGTCCCTTTCCTACCA R GGACCACTAGGGCTGAGAAG 
Pitx2c_prom  F TCTCCTCTCCCCCACCTTAT R  AGGGATGGTTCTGTCTGCAC 
Tbx1_prom  F CGGAAGGGAAGACATGAAAA R  ACGCTCCCCAAGTTCTTCTT 
Myf5 -40   F CACCCAAGGCCCATTACCG R GTTGTCCTCGGGCCAATACTG 
from Zacharias et al. 2010 (http://www.ncbi.nlm.nih.gov/pubmed/21035439) 
Myf5 pro F AATGTCTTGCTACCGTGCTG R GGTCCCTTTGACGCTAATGA  
Myf5 -10 kb F TCCTTCTCCCACTCTTTCTGA  R GACATGGCAACTGTGGAATG 
Primers for Fig. 5B 
ChIP-qPCR 
Tbx1 F TTATGCACCTGCCCAAGACT R GGCTGTCAAGAGGTCGTTTC 
Tcf21 F CAGCTCATGTAGGCATCTGG R CCGAGGATAAAGCAGGAGTG 
Lhx2a F TGGCTTTGGTCTCAGAATCC R TCCTTTCTGCGGGTCTCTAA 
Lhx2b F GGCCACATGGCTTTCCCCCAAT R TCTTCCACCCCCTCCACACCTT 
Lhx2c F TGGGTGGACATGCCCTTTCACCT R AGAGCCTCAAACCTCACTGTGGC 
qPCR 
Lhx2 F CCAGCTTCGGACAATGAAGT R TTTCCTGCCGTAAAAGGTTG 
Tbx1 F GCTGTGGGACGAGTTCAATC R ACGTGGGGAACATTCGTCT 
Tcf21 F GGCTGGCGTCCAGCTACATCG R TGCCGGCCACCATAAAGGGC 
Pitx2 F TGGACCAACCTTACGGAAGC R GACAGAGACGTTGACGTGAGG  
 
E17 E14.5 
WT Lhx2mKO Tcf21-/- Lhx2-/-   Tbx1+/- Tbx+/-Lhx2+/- Tbx1-/- Tbx1-/-Lhx2-/- 
Craniofacial anomalies   0% 0% 100% 100%           
Cleft palate 0% 0% 100% 100%           
Cardiovascular defects   0% 50% 30% N/A           
Tetralogy of 
Fallot 0% 
30% 
(4/13)  
30% 
(3/11) N/A           
Persistent truncus arteriosus (PTA) - - - N/A           
Transposition of the great arteries - 0% 0% N/A           
Ventricular septal defects   - 7% (1/13) 0% N/A   0% 20% (2/10) 100% (5/5) 100% (4/4) 
Double outlet Right 
Ventricle - 
15% 
(2/13)   N/A           
Aourtic arch anomalies   0% 0% 0% 0%           
Total       n=10 n=13 n=11 n=10   n=11 n=10 n=5 n=4 
 
Supplementary experimental procedures: 
 
FACS isolation and microarray screen 
Cells were dispersed using a mixture of 0.1% Trypsin and 0.1% Collagenase D (Roche) diluted 
in F12 (GIBCO). FACS Aria (BD Bioscience) was used to isolate YFP+ cells. RNA was purified 
using QIAzol Lysis Reagent (QIAGEN). Due to the small tissue samples, mRNA was amplified 
(Ambion, Message-Amp kit). Hybridization and detection of the mRNAs were performed on 
Affymetrix GeneChip mouse expression arrays. 
 
X-Gal staining, histology, immunohistochemistry and in situ hybridization 
Antibodies used in the study were as follows: Pax7, MyHC, Pecam1, AP2 and Isl1 (29, 60) and 
mouse monoclonal antibody (Developmental Studies Hybridoma Bank; 1:5-1:10); MyoD, mouse 
monoclonal (Santa Cruz; 1:200); Lhx2, Rabbit polyclonal (Santa Cruz; 1:100); phospho-histone 
H3, mouse monoclonal (Cell Signaling; 1:200). Secondary antibodies used were Cy2-, Cy3-, or 
Cy5-conjugated anti-mouse or anti-rabbit IgG; Cy3-conjugated anti-mouse IgG1; and Cy5-
conjugated anti-mouse IgG2b (Jackson ImmunoResearch, 1:200). Images were obtained with a 
Nikon 90i florescent microscope with the Image Pro Plus program (Media Cybernetics, Inc.). 
Images were assembled using Photoshop CS software (Adobe), PTGui stitching software 
(http://www.ptgui.com) and Canvas (ACD Systems). Percentages given in the text were based 
on the analysis of ≥6 sections from at least two embryos.  
 
ChIP assay: 
The pharyngeal arch tissue was dissected from E9.5 mice, cross-linked with 1% formaldehyde 
and followed by the addition of glycine to quench formaldehyde. Tissue was washed with ice-
cold PBS and lysed in lysis buffer containing a protease inhibitor mixture (Roche). Lysates were 
sonicated to yield sheared DNA amplicons averaging less than 500 bp. Pre-clearing was 
performed with salmon sperm DNA, IgGs from the same origin as the primary antibody, and 45 
μl of either protein A or G-Sepharose.  Samples were incubated with the following antibodies: 
goat anti-Pitx2 (C-16, Santa Cruz Biotechnology) overnight at 4 °C followed by the addition of 
protein A or G-Sepharose for 1 h at 4°C. After several washes, the DNA was eluted from the 
sepharose beads following incubation overnight at 65°C with RNase A and proteinase K 
treatment for 2 h at 45°C. DNA was purified with QIAquick columns (Qiagen). PCR analysis 
using SYBR Green was done to evaluate the relative abundance of sequences in input and IP 
material. Primers used are listed in supplemental Table 2. Additional ChIP antibodies were Tbx1 
(34-9800, Invitrogen); Pitx2 (C16 -sc8748 and H80 - sc33147, Santa Cruz); Tcf21 (ab32981, 
Abcam, and sc15006, Santa Cruz) and IgG control (ab37355, Abcam). All antibodies we used at 
5ug per ChIP experiment. 
 
Vascular Casting  
Pregnant mice at E17.5 were anaesthetized by light Isoflurane and one horn of the uterus was 
surgically exposed. Viable embryos from the uterus were removed and kept in ice-cold PBS. 
The umbilical artery was exposed by opening the yolk sac and injected with a mixture of PBS 
and Red Baston’s No. 17 Casting Solution for 3-4 min. Embryonic tissues were digested by 
incubation in 20% KCl for 24-48 hours at room temperature. Casts were examined and 
photographed on a dissecting microscope. 
 
 
 
 
 
 
 
 Figure S1: A screen for PM-enriched regulators 
A-B, An example of a single FACS isolation procedure, using cells from either inter-limb somites 
(A) or pharyngeal arches (B). Whole mount in situ hybridization of E9.5 embryos using Cyp1b1 
(C), Rxrg (D), Lmo2 (E) and Edn1 (F) riboprobes. 
 
Figure S2: Lhx2 is not expressed in PM endothelial cells 
A, Whole-mount in situ hybridization for Lhx2 at E9.5. B, Lhx2 (green) and Pecam1 (red) 
staining of of the area marked in (A). 1st, 2nd and 3rd denote the relevant pharyngeal arch. 
  
Figure S3: PM gene expression patterns by in situ sections 
A-E’, Whole-mount in situ hybridization for the indicated genes (left of each image) of E9.5 
embryos with the indicated genotypes (black rectangles). Arrows/Arrowheads mark the PM: 
white arrows, unchanged expression; black arrowheads, down-regulated genes; white 
arrowheads, upregulated genes. A-H, sections for selected embryos, with the indicated 
genotypes and in situ probes. Arrowheads indicate core of the PM. 
 
Figure S4: evaluation of PM gene expression in Tcf21, Pitx2 and Lhx2 mutants 
A, RT-qPCR for selected PM regulators in Lhx2, Tcf21 and Pitx2 mutants, heterozygous and 
controls.  B, X-gal staining of Tcf21-/- (Tcf21LacZ/LacZ) at E9.75 compared to Tcf21+/- controls (left). 
Co-immunofluorescence (at E9.5) for Tbx1 and Pitx2 (βGal), or X-gal staining (at E12.5), in 
Pitx2-/-  and Pitx2+/- control embryos (right). Significant statistical differences (p<0.05) are 
marked with an asterix. To test whether PM cells were present in Tcf21 mutants; we analyzed 
E9.5 control Tcf21 (Tcf21LacZ /+) and null (Tcf21LacZ/LacZ) embryos. X-Gal staining in the mesoderm 
core of control and Tcf21 mutants was comparable at E9.5. In line with this result, pharyngeal 
muscles were not significantly affected in E14 Tcf21 mutants. We used the same methodology 
in Pitx2 control (Pitx2LacZ/+) and mutant (Pitx2LacZ/LacZ) pharyngeal arches. The mesodermal core, 
as shown in sections of the 1st arch stained for Tbx1 and Pitx2 (ßGal) proteins, was reduced in 
Pitx2 mutants. 
 
Figure S5: ChIP data 
A. ChIP for proximal promoters of PM regulators, using Tbx1, Pitx2 and Tcf21 antibodies. The 
gene expression shown by RT-qPCR is presented relative to the total input. B. Additional Pitx2 
binding sites on the Tbx1 promoter. C. Three putative Lhx2 binding sites on the Myf5 MAE. D, 
Western blot and ChIP for Myf5 MAE, using HA antibody and Lhx2-HA construct in vitro (D). E. 
An in vivo ChIP experiment using pharyngeal arch tissues at E9.5 with Tbx1, Pitx2 and Tcf21 
antibodies suggest a range of direct interactions with the Myf5 MAE. 
 
Figure S6: Comparable apoptosis in the PM of controls and Lhx2 mutants 
A, B, Transverse sections of control (A) and Lhx2 mutant (B) E11.5 embryos, showing the core 
of the PM.  Co-immunofluorescence of Pax7-MyoD and activated caspase3 (Casp3) cells in 
control (A) and Lhx2 mutant (B) embryos. C-E, Myf5 expression (X-Gal staining) in Lhx2 control 
(C), heterozygous (D) and homozygote (E) E11.5 embryos, which are also heterozygous for the 
Myf5nLacZ reporter. Insets in show the area depicted by the dotted line in C. Arrowheads indicate 
change in muscle patterning. eom- extraocular muscles, 1st/2nd – first/second pharyngeal arch 
muscle progenitors, fl – forelimb, som – somites. 
 
 
Figure S7: ISH analysis for Lhx2-/- embryos 
Whole mount in situ hybridization for in E9.5 embryos (Lhx2-/- and controls) for Fgf8 (A-B) Bmp4 
(C-D) Dlx5 (E-F) Sox10 (G-H) Twist (I-J) and Isl1 (K-L). White arrowheads indicate 
downregulation of Bmp4 in the eye of Lhx2-/- compared to controls (C-D), or defected neural 
crest migration in Lhx2-/- compared to controls (G-H).  
 
Figure S8: Heart malformations in Tcf21-/- embryos 
A-C, Hematoxylin and Eosin (H&E) staining of heart paraffin sections in control hearts (A) and 
enlarged insets (B-C). D-F, Tcf21-/- mutants display tetralogy of Fallot (TOF), characterized by 
both VSD and overriding aorta (E, arrowheads); as well as detached epicardium and aberrant 
coronary vessels (F, white arrows) compared to the controls (C). a – Aorta; p – Pulmonary 
artery; lv- Left ventricle; la- Left atrium; rv- Right ventricle; ra- Right atrium; endo’ – 
Endocardium; myo’ – Myocardium; epi’ -  Epicardium.    
 
Table 1. Genotypes/phenotypes summary table  
A table summarizing craniofacial, cardiovascular and aortic arch defects in Lhx2mKO, Lhx2null, 
Tcf21null and control E17.5 embryos. Because VSD was evident in all hearts of Tbx1-/- (n=5), we 
could not see differences in Tbx1-/-Lhx2-/- (n=4) double mutants due to the saturation of this 
phenotype. 
 
Table 2. list of primers  
 
 














